The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil

Silla, 1999, Sickle cell disease: a serious and unknown problem of public health in Brazil, J. Pediatr. (Rio J)., 75, 145, 10.2223/JPED.288 Platt, 1994, Mortality in sickle cell disease. Life expectancy and risk factors for early death, N. Engl. J. Med., 330, 1639, 10.1056/NEJM199406093302303 Sankaran, 2015, Anemia: progress in molecular mechanisms and therapies, Nat. Med., 21, 221, 10.1038/nm.3814 Galarneau, 2010, Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation, Nat. Genet., 42, 1049, 10.1038/ng.707 Thein, 2009, Control of fetal hemoglobin: new insights emerging from genomics and clinical implications, Hum. Mol. Genet., 18, R216, 10.1093/hmg/ddp401 Bauer, 2013, An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level, Science, 342, 253, 10.1126/science.1242088 Menzel, 2007, A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15, Nat. Genet., 39, 1197, 10.1038/ng2108 Lettre, 2008, DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease, Proc. Natl. Acad. Sci. U. S. A., 105, 11869, 10.1073/pnas.0804799105 Bae, 2012, Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans, Blood, 120, 1961, 10.1182/blood-2012-06-432849 Ware, 2010, How I use hydroxyurea to treat young patients with sickle cell anemia, Blood, 115, 5300, 10.1182/blood-2009-04-146852 Stadhouders, 2014, HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers, J. Clin. Invest., 124, 1699, 10.1172/JCI71520 Menzel, 2014, Global genetic architecture of an erythroid quantitative trait locus, HMIP-2, Ann. Hum. Genet., 78, 434, 10.1111/ahg.12077 Ware, 2002, Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy, Blood, 99, 10, 10.1182/blood.V99.1.10 Uda, 2008, Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia, Proc. Natl. Acad. Sci. U. S. A., 105, 1620, 10.1073/pnas.0711566105 Flanagan, 2012, Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia, Br. J. Haematol., 157, 240, 10.1111/j.1365-2141.2012.09061.x Sheehan, 2014, Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia, PLoS One, 9, 10.1371/journal.pone.0110740